COVID-19
Conditions
Interventions
intervention group:receiving pharmacologic treatment and press needles intervention
control group:only receiving pharmacologic treatment
Sponsors
Baiyun Branch,NanFang Hospital,Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1) Age from 14 to 90 years old, regardless of gender; 2) patients with COVID-19, mild or common type;
Exclusion criteria
Exclusion criteria: 1) Known or suspected allergic history or serious adverse reactions to metal and tape in intradermal needle, or allergic constitution. 2) Complicated with serious heart and lung diseases, kidney disease, diabetes, advanced tumors, hematological and hematopoietic system diseases, or serious or progressive diseases of other systems. 3) patients with comorbid neurological or mental disorders who were unable to cooperate or unwilling to cooperate. 4) pregnant and lactating women. 5) Other conditions that the investigator considers inappropriate to participate in the trial. 6) those who are participating in other COVID-19 intervention clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| ,the duration of fever symptom;the duration of positive nucleic acid;rate of condition worsened;C-reactive protein (CRP) ;complete blood count; | — |
Countries
China
Contacts
Public ContactYaqiu Long
Baiyun Branch,NanFang Hospital,Southern Medical University
Outcome results
None listed